Work

Metabolic Profiles and Body Composition Changes in Treatment-Naï ve HIV-Infected Patients Treated with Raltegravir 400 mg bid-based vs. Efavirenz 600 mg qhs-based Combination Therapy: 48-Week Data

Year: 2009

Type: article

Study design: Clinical Trial

Authors: E DeJesus, Adriano Lazzarin, JL Lennox, D. Berger, Richard B. Pollard, José Valdez Madruga, Jing Zhao, Angela Rodgers, Randi Y. Leavitt, Peter Sklar

Language: English

Topic: HIV-related health complications and treatments

Subfield: Emergency Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2185130075

FWCI: 0.702

Cites:

Cited by: 3

Related to: 10